Xencor | XNCR - 매출원가





매출원가 변화 날짜
AbbVie USD 4.55B 757M 2025-12
Alnylam Pharmaceuticals USD 267.72M 67.57M 2025-12
Amgen USD 1.79B 128M 2025-12
AstraZeneca USD 3.27B 471M 2025-12
Biogen USD 810.1M 205.1M 2025-09
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Cytokinetics USD 99.23M 13.32M 2025-09
GlaxoSmithKline GBP 2.61B 377M 2025-12
J&J USD 7.97B 689M 2025-12
Karyopharm Therapeutics USD 37.43M 2.41M 2024-09
MacroGenics USD 10.12M 34.18M 2025-12
Merck USD 3.32B 531M 2025-12
Novartis USD 3.54B 3M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Xencor USD 61.66M 50.95M 2025-06